The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
RNA-dependent RNA targeting by CRISPR-Cas9
Abstract
Double-stranded DNA (dsDNA) binding and cleavage by Cas9 is a hallmark of type II CRISPR-Cas bacterial adaptive immunity. All known Cas9 enzymes are thought to recognize DNA exclusively as a natural substrate, providing protection against DNA phage and plasmids. Here, we show that Cas9 enzymes from both subtypes II-A and II-C can recognize and cleave single-stranded RNA (ssRNA) by an RNA-guided mechanism that is independent of a protospacer-adjacent motif (PAM) sequence in the target RNA. RNA-guided RNA cleavage is programmable and site-specific, and we find that this activity can be exploited to reduce infection by single-stranded RNA phage in vivo. We also demonstrate that Cas9 can direct PAM-independent repression of gene expression in bacteria. These results indicate that a subset of Cas9 enzymes have the ability to act on both DNA and RNA target sequences, and suggest the potential for use in programmable RNA targeting applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures














Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recently, scientists have also uncovered new CRISPR-Cas systems (Cas13) that can target RNA instead of DNA34,35.”
From CRISPR Ethics: Moral Considerations for Applications of a Powerful Tool (2019) · cites this paper as [35]
In the citing paper
“Strutt and colleagues demonstrated that Cas9 subtypes II-A and II-C can recognize and cleave RNA in a directed manner utilizing RNA–RNA interactions independent of the presence of a PAM site in the target RNA molecule (Strutt et al., 2018). This cleavage protected E. coli cells from infection with bacteriophage MS2 particles, suggesting that Cas9 can provide cellular defense against both DNA and R”
From Delivering CRISPR: a review of the challenges and approaches (2018) · cites this paper as Strutt et al., 2018
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cutadapt removes adapter sequences from high-throughput sequencing reads
Martin, M. (2011) · EMBnet.journal · doi:10.14806/ej.17.1.200 · Cited by 33,889
HTSeq—a Python framework to work with high-throughput sequencing data
Anders, S., Pyl, P. T., & Huber, W. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu638 · Cited by 21,464
Guindon, S., Dufayard, J.-F., Lefort, V., Anisimova, M., Hordijk, W., & Gascuel, O. (2010) · Systematic Biology · doi:10.1093/sysbio/syq010 · Cited by 18,376
Mfold web server for nucleic acid folding and hybridization prediction
Zuker, M. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg595 · Cited by 13,404
McCarthy, D. J., Chen, Y., & Smyth, G. K. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks042 · Cited by 5,195
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016 · cited 4×
“When using sgRNAs designed to recognize a sequence in the GFP gene adjacent to the appropriate PAM for SauCas9 (NNGRRT) or SpyCas9 (NGG), GFP expression is significantly reduced (Figure 4A) consistent with CRISPR-interference (CRISPRi) (Qi et al., 2013; Gilbert et al., 2014).”
MethodInfluentialSelf-citationDNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation
Gilbert, L. A., Horlbeck, M. A., Adamson, B., Villalta, J. E., Chen, Y., Whitehead, E. H., Guimaraes, C., Panning, B., Ploegh, H. L., Bassik, M. C., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.029 · Cited by 2,728
In vivo genome editing using Staphylococcus aureus Cas9
Ran, F. A., Cong, L., Yan, W. X., Scott, D. A., Gootenberg, J. S., Kriz, A. J., Zetsche, B., Shalem, O., Wu, X., Makarova, K. S., et al. (2015) · Nature · doi:10.1038/nature14299 · Cited by 2,687
RNA-guided editing of bacterial genomes using CRISPR-Cas systems
Jiang, W., Bikard, D., Cox, D., Zhang, F., & Marraffini, L. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2508 · Cited by 2,429
Crystal structure of Cas9 in complex with guide RNA and target DNA
Nishimasu, H., Ran, F. A., Hsu, P. D., Konermann, S., Shehata, S. I., Dohmae, N., Ishitani, R., Zhang, F., & Nureki, O. (2014) · Cell · doi:10.1016/j.cell.2014.02.001 · Cited by 2,306
PANDAseq: paired-end assembler for Illumina sequences
Masella, A. P., Bartram, A. K., Truszkowski, J. M., Brown, D. G., & Neufeld, J. D. (2012) · BMC Bioinformatics · doi:10.1186/1471-2105-13-31 · Cited by 2,132
Improving CRISPR-Cas nuclease specificity using truncated guide RNAs
Fu, Y., Sander, J. D., Reyon, D., Cascio, V. M., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2808 · Cited by 1,993 · cited 1×
“Previous work and models suggest that shorter guide segments should be more sensitive to mismatches and lead to higher fidelity Cas9 targeting (Fu et al., 2014; Bisaria et al., 2017).”
BackgroundZuris, J. A., Thompson, D. B., Shu, Y., Guilinger, J. P., Bessen, J. L., Hu, J. H., Maeder, M. L., Joung, J. K., Chen, Z.-Y., & Liu, D. R. (2015) · Nature Biotechnology · doi:10.1038/nbt.3081 · Cited by 1,460 · cited 2×
“, 2015) and facilitating delivery to cells as a pre-assembled RNP (Zuris et al., 2015; Mout et al., 2017) The RNA-targeting capability of SauCas9 and related Cas9 enzymes offers the advantage of repressing viruses whose lifecycles do not involve a DNA genome or intermediate, thereby rendering them inaccessible to Cas9…”
BackgroundIn vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni
Kim, E., Koo, T., Park, S. W., Kim, D., Kim, K., Cho, H.-Y., Song, D. W., Lee, K. J., Jung, M. H., Kim, S., et al. (2017) · Nature Communications · doi:10.1038/ncomms14500 · Cited by 715
Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition
Kleinstiver, B. P., Prew, M. S., Tsai, S. Q., Nguyen, N. T., Topkar, V. V., Zheng, Z., & Joung, J. K. (2015) · Nature Biotechnology · doi:10.1038/nbt.3404 · Cited by 611
Direct cytosolic delivery of CRISPR/Cas9-ribonucleoprotein for efficient gene editing
Mout, R., Ray, M., Yesilbag Tonga, G., Lee, Y.-W., Tay, T., Sasaki, K., & Rotello, V. M. (2017) · ACS Nano · doi:10.1021/acsnano.6b07600 · Cited by 579
Classification and evolution of type II CRISPR-Cas systems
Chylinski, K., Makarova, K. S., Charpentier, E., & Koonin, E. V. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku241 · Cited by 498 · cited 2×
“Phylogenetic tree construction and RNA folding Cas9 homolog sequences were obtained from Chylinski and colleagues (Chylinski et al., 2014).”
MethodMolecular structure of r(GCG)d(TATACGC): a DNA–RNA hybrid helix joined to double helical DNA
Wang, A. H.-J., Fujii, S., van Boom, J. H., van der Marel, G. A., van Boeckel, S. A. A., & Rich, A. (1982) · Nature · doi:10.1038/299601a0 · Cited by 210
Research works printed but not linked: 46
- Abudayyeh, 2016, C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector, Science, 353, aaf5573, 10.1126/science.aaf5573 · DOI · Paper page
- Anders, 2014, Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease, Nature, 513, 569, 10.1038/nature13579 · DOI · Paper page
- Batra, 2017, Elimination of toxic microsatellite repeat expansion RNA by RNA-Targeting Cas9, Cell, 170, 899, 10.1016/j.cell.2017.07.010 · DOI · Paper page
- Bercy, 2015, Hairpins under tension: RNA versus DNA, Nucleic Acids Research, 43, gkv860, 10.1093/nar/gkv860 · DOI
- Bisaria, 2017, Lessons from enzyme kinetics reveal specificity principles for rna-guided nucleases in RNA interference and CRISPR-based genome editing, Cell Systems, 4, 21, 10.1016/j.cels.2016.12.010 · DOI
- Chylinski, 2013, The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems, RNA Biology, 10, 726, 10.4161/rna.24321 · DOI · Paper page
- Cong, 2013, Multiplex genome engineering using CRISPR/Cas systems, Science, 339, 819, 10.1126/science.1231143 · DOI · Paper page
- Crooks, 2004, WebLogo: a sequence logo generator, Genome Research, 14, 1188, 10.1101/gr.849004 · DOI · Paper page
- Dai, 2017, In situ structures of the genome and genome-delivery apparatus in a single-stranded RNA virus, Nature, 541, 112, 10.1038/nature20589 · DOI · Paper page
- Deveau, 2008, Phage response to CRISPR-encoded resistance in Streptococcus thermophilus, Journal of Bacteriology, 190, 1390, 10.1128/JB.01412-07 · DOI · Paper page
- East-Seletsky, 2016, Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection, Nature, 538, 270, 10.1038/nature19802 · DOI · Paper page
- Friedland, 2015, Characterization of Staphylococcus aureus Cas9: a smaller Cas9 for all-in-one adeno-associated virus delivery and paired nickase applications, Genome Biology, 16, 257, 10.1186/s13059-015-0817-8 · DOI · Paper page
- Fu, 2016, Distinct patterns of Cas9 mismatch tolerance in vitro and in vivo, Nucleic Acids Research, 44, 5365, 10.1093/nar/gkw417 · DOI
- Garneau, 2010, The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA, Nature, 468, 67, 10.1038/nature09523 · DOI · Paper page
- Gasiunas, 2012, Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria, PNAS, 109, E2579, 10.1073/pnas.1208507109 · DOI · Paper page
- Gorski, 2017, RNA-based recognition and targeting: sowing the seeds of specificity, Nature Reviews Molecular Cell Biology, 18, 215, 10.1038/nrm.2016.174 · DOI · Paper page
- Hirano, 2016, Structure and engineering of francisella novicida Cas9, Cell, 164, 950, 10.1016/j.cell.2016.01.039 · DOI · Paper page
- Jiang, 2015, STRUCTURAL BIOLOGY. A Cas9-guide RNA complex preorganized for target DNA recognition, Science, 348, 1477, 10.1126/science.aab1452 · DOI · Paper page
- Jinek, 2012, A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity, Science, 337, 816, 10.1126/science.1225829 · DOI · Paper page
- Kerpedjiev, 2015, Forna (force-directed RNA): Simple and effective online RNA secondary structure diagrams, Bioinformatics, 31, 3377, 10.1093/bioinformatics/btv372 · DOI · Paper page
- Kou, 2016, Benefits and Challenges with Applying Unique Molecular Identifiers in Next Generation Sequencing to Detect Low Frequency Mutations, PLoS One, 11, e0146638, 10.1371/journal.pone.0146638 · DOI
- Langmead, 2012, Fast gapped-read alignment with Bowtie 2, Nature Methods, 9, 357, 10.1038/nmeth.1923 · DOI · Paper page
- Liu, 2016, Targeting cellular mRNAs translation by CRISPR-Cas9, Scientific Reports, 6, srep29652, 10.1038/srep29652 · DOI
- Loughrey, 2014, SHAPE-Seq 2.0: systematic optimization and extension of high-throughput chemical probing of RNA secondary structure with next generation sequencing, Nucleic Acids Research, 42, e165, 10.1093/nar/gku909 · DOI
- Ma, 2015, Single-Stranded DNA cleavage by divergent CRISPR-Cas9 Enzymes, Molecular Cell, 60, 398, 10.1016/j.molcel.2015.10.030 · DOI
- Mohanraju, 2016, Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems, Science, 353, aad5147, 10.1126/science.aad5147 · DOI · Paper page
- Nelles, 2015, Applications of Cas9 as an RNA-programmed RNA-binding protein, BioEssays, 37, 732, 10.1002/bies.201500001 · DOI
- Nelles, 2016, Programmable RNA tracking in live cells with CRISPR/Cas9, Cell, 165, 488, 10.1016/j.cell.2016.02.054 · DOI · Paper page
- Nishimasu, 2015, Crystal structure of Staphylococcus aureus Cas9, Cell, 162, 1113, 10.1016/j.cell.2015.08.007 · DOI · Paper page
- O'Connell, 2014, Programmable RNA recognition and cleavage by CRISPR/Cas9, Nature, 516, 263, 10.1038/nature13769 · DOI · Paper page
- Oakes, 2016, Profiling of engineering hotspots identifies an allosteric CRISPR-Cas9 switch, Nature Biotechnology, 34, 646, 10.1038/nbt.3528 · DOI · Paper page
- Pei, 2008, PROMALS3D: a tool for multiple protein sequence and structure alignments, Nucleic Acids Research, 36, 2295, 10.1093/nar/gkn072 · DOI · Paper page
- Phanstiel, 2014, Sushi.R: flexible, quantitative and integrative genomic visualizations for publication-quality multi-panel figures, Bioinformatics, 30, 2808, 10.1093/bioinformatics/btu379 · DOI · Paper page
- Rehmsmeier, 2004, Fast and effective prediction of microRNA/target duplexes, RNA, 10, 1507, 10.1261/rna.5248604 · DOI · Paper page
- Rio, 2012, Filter-binding assay for analysis of RNA-protein interactions, Cold Spring Harbor Protocols, 2012, pdb.prot071449, 10.1101/pdb.prot071449 · DOI
- Robinson, 2010, edgeR: a bioconductor package for differential expression analysis of digital gene expression data, Bioinformatics, 26, 139, 10.1093/bioinformatics/btp616 · DOI · Paper page
- Sampson, 2013, A CRISPR/Cas system mediates bacterial innate immune evasion and virulence, Nature, 497, 254, 10.1038/nature12048 · DOI · Paper page
- Shmakov, 2015, Discovery and functional characterization of diverse class 2 CRISPR-Cas systems, Molecular Cell, 60, 385, 10.1016/j.molcel.2015.10.008 · DOI · Paper page
- Smargon, 2017, Cas13b Is a Type VI-B CRISPR-Associated RNA-Guided RNase differentially regulated by accessory proteins Csx27 and Csx28, Molecular Cell, 65, 618, 10.1016/j.molcel.2016.12.023 · DOI · Paper page
- Smith, 2017, UMI-tools: modeling sequencing errors in Unique Molecular Identifiers to improve quantification accuracy, Genome Research, 27, 491, 10.1101/gr.209601.116 · DOI · Paper page
- Sternberg, 2012, Mechanism of substrate selection by a highly specific CRISPR endoribonuclease, RNA, 18, 661, 10.1261/rna.030882.111 · DOI
- Sternberg, 2014, DNA interrogation by the CRISPR RNA-guided endonuclease Cas9, Nature, 507, 62, 10.1038/nature13011 · DOI · Paper page
- Szczelkun, 2014, Direct observation of R-loop formation by single RNA-guided Cas9 and Cascade effector complexes, PNAS, 111, 9798, 10.1073/pnas.1402597111 · DOI · Paper page
- Wright, 2016, Biology and applications of CRISPR systems: harnessing nature's toolbox for genome engineering, Cell, 164, 29, 10.1016/j.cell.2015.12.035 · DOI · Paper page
- Yamada, 2017, Crystal structure of the minimal cas9 from campylobacter jejuni reveals the molecular diversity in the CRISPR-Cas9 systems, Molecular Cell, 65, 1109, 10.1016/j.molcel.2017.02.007 · DOI · Paper page
- Zhang, 2015, DNase H activity of neisseria meningitidis Cas9, Molecular Cell, 60, 242, 10.1016/j.molcel.2015.09.020 · DOI
Cited by
The next generation of CRISPR–Cas technologies and applications
Pickar-Oliver, A., & Gersbach, C. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0131-5 · Cited by 1,459
CRISPR-Cas guides the future of genetic engineering
Knott, G. J., & Doudna, J. A. (2018) · Science · doi:10.1126/science.aat5011 · Cited by 1,410
Self-citationDelivering CRISPR: a review of the challenges and approaches
Lino, C. A., Harper, J. C., Carney, J. P., & Timlin, J. A. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1474964 · Cited by 1,185
RNA-based therapeutics: an overview and prospectus
Zhu, Y., Zhu, L., Wang, X., & Jin, H. (2022) · Cell Death & Disease · doi:10.1038/s41419-022-05075-2 · Cited by 623
CRISPR Gene Therapy: Applications, Limitations, and Implications for the Future
Uddin, F., Rudin, C. M., & Sen, T. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01387 · Cited by 581
Metadata
- Authors
- Strutt, S. C., Torrez, R. M., Kaya, E., Negrete, O. A., & Doudna, J. A.
- Affiliations
- Department of Molecular and Cell Biology, University of California, Berkeley, United States
- Sandia National Laboratories, Biotechnology and Bioengineering Department, Livermore, United States
- Venue
- eLife
- Publisher
- eLife Sciences Publications, Ltd
- Published
- 2018-01-05
- Volume
- 7
- ISSN
- 2050-084X
- PMC
- PMC5796797
- Cited by
- 186
- References
- 19
- Language
- en
- Licence
- creativecommons.org/licenses/by/4.0/ (vor)
- creativecommons.org/licenses/by/4.0/ (am)
- creativecommons.org/licenses/by/4.0/ (tdm)
- Funders
- National Science Foundation (MCB-1244557)
- Howard Hughes Medical Institute
- German Academic Exchange Program
- Laboratory Directed Research and Development (U.S. Department of Energy's National Nuclear Security Administration under contract DE-NA0003525)
- Paul Allen Frontiers Science Program
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.